Framework, screening and access to treatment: an analysis of recent European and French decisions
In 2026, European and French health news shows an increasingly clear guiding principle: better…
What changes does the recent EFSA recommendation have for food products and therapeutic uses derived from the plant?
For several years, products derived from hemp and other plants have been navigating between market enthusiasm and expectations…
CBD, saliva tests and driving: what are the risks in France?
The issue is causing concern among many motorists: is it possible to test positive in a saliva test after consuming CBD?
Better sleep by targeting anxiety: what clinical trials on hemp-based supplements reveal
When anxiety creeps in at night, sleep often becomes lighter, more fragmented, or simply more difficult…
Corporate supplements and the quest for serenity: a comparative look at evidence and practices
In the workplace, the quest for serenity can no longer be reduced to a few added wellness benefits on the sidelines…
Choosing between indoor and greenhouse cultivation: aromas, analyses and energetic impact of hemp buds
When comparing hemp buds grown indoors and in a greenhouse, the discussion doesn't end there…
CBD, risk of saliva testing and new European limits
The link between CBD, the risk of saliva testing, and new European limits is generating increasing discussion…
From seed to laboratory: what the new health regulations change for supply chains and controls
Between the seed sown at the beginning of a supply chain and the finished product analyzed before it is placed on the…
When EFSA's opinion on extracts reshapes the market, food safety and roadside checks
When EFSA publishes an opinion on extracts, extraction solvents or residues present in food,…
Key indicators for recognizing a reliable hemp concentrate: laboratory analyses, aromatic profiles, and risks of adulteration
Choosing a hemp concentrate may seem simple at first glance: a nice appearance, a high percentage…
